Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Igor KlyubinMichael J Rowan

Abstract

The current development of immunotherapy for Alzheimer's disease is based on the assumption that human-derived amyloid beta protein (Abeta) can be targeted in a similar manner to animal cell-derived or synthetic Abeta. Because the structure of Abeta depends on its source and the presence of cofactors, it is of great interest to determine whether human-derived oligomeric Abeta species impair brain function and, if so, whether or not their disruptive effects can be prevented using antibodies. We report that untreated ex vivo human CSF that contains Abeta dimers rapidly inhibits hippocampal long-term potentiation in vivo and that acute systemic infusion of an anti-Abeta monoclonal antibody can prevent this disruption of synaptic plasticity. Abeta monomer isolated from human CSF did not affect long-term potentiation. These results strongly support a strategy of passive immunization against soluble Abeta oligomers in early Alzheimer's disease.

References

Nov 1, 1987·Journal of Neuropathology and Experimental Neurology·C L JoachimK S Kosik
Mar 16, 2001·Trends in Neurosciences·W L KleinC E Finch
May 15, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R G M MorrisC O'Carroll
Dec 21, 2004·Nature Neuroscience·James P ClearyKaren H Ashe
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dominic M WalshDennis J Selkoe
May 11, 2005·Neurology·S GilmanUNKNOWN AN1792(QS-21)-201 Study Team
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
Nov 4, 2006·Science·Erik D Roberson, Lennart Mucke
Mar 10, 2007·Nature Reviews. Drug Discovery·Leslie M ShawJohn Q Trojanowski

❮ Previous
Next ❯

Citations

Dec 17, 2009·Brain Structure & Function·Thomas Wisniewski, Allal Boutajangout
Apr 21, 2010·Journal of Clinical Immunology·Brian O'NuallainAlan Solomon
Dec 5, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sriram VennetiJulia Kofler
Aug 24, 2012·Molecular Neurobiology·Robert NisticòGraham Collingridge
Feb 16, 2010·Archives of Biochemistry and Biophysics·Paulius CizasVilmante Borutaite
May 5, 2011·Biochemistry·Alice Y YamCleo M Salisbury
Nov 23, 2012·ACS Chemical Neuroscience·Pauline T VelascoWilliam L Klein
Dec 29, 2009·Nature Neuroscience·Wei WeiRoberto Malinow
Feb 9, 2010·Nature Reviews. Neurology·Cynthia A Lemere, Eliezer Masliah
Feb 17, 2010·Nature Reviews. Neurology·Kaj BlennowHenrik Zetterberg
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Feb 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Deepak R ThakkerLisa L Shafer
Nov 6, 2009·The Journal of Biological Chemistry·Sharad P AdekarBrian O'Nuallain
Feb 26, 2011·The Journal of Biological Chemistry·Suman NagSudipta Maiti
Apr 21, 2010·Brain : a Journal of Neurology·Jessica M Mc DonaldUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Apr 12, 2013·Brain : a Journal of Neurology·Sylvain E LesnéKaren H Ashe
May 28, 2013·Protein Engineering, Design & Selection : PEDS·Nicola AcerraJody M Mason
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
May 5, 2012·Journal of Neuroinflammation·Julia KoflerClayton A Wiley
May 8, 2009·Molecular Neurodegeneration·Philippe MarambaudValérie Vingtdeux
Nov 26, 2009·Molecular Neurodegeneration·Ganesh M Shankar, Dominic M Walsh
Sep 24, 2011·Molecular Neurodegeneration·Andreas M GrabruckerTobias M Boeckers
Dec 6, 2012·Translational Neurodegeneration·Suzhen DongZheng Zhao
Jul 21, 2010·Alzheimer's Research & Therapy·Kerensa BroersenJoost Schymkowitz
Aug 4, 2011·Disease Models & Mechanisms·Sei-Kyoung ParkSusan W Liebman
Aug 17, 2012·Journal of Psychiatry & Neuroscience : JPN·Timothy J RevettSatyabrata Kar
Feb 24, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·David Prvulovic, Harald Hampel
Feb 21, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William J MeilandtLennart Mucke
Mar 1, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tatiana MelnikovaDavid R Borchelt
Apr 14, 2010·Biomarkers in Medicine·Henrik ZetterbergKaj Blennow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.